skip to main content
Idioma:
previous page 1 Resultados 2 3 4 5 next page
Mostrar Somente
Refinado por: idioma: Russo remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Female Characters in Doctor Zhivago and Their Role in the Fate of the Protagonist
Female Characters in Doctor Zhivago and Their Role in the Fate of the Protagonist
Material Type:
Artigo 		Adicionar ao Meu Espaço

Female Characters in Doctor Zhivago and Their Role in the Fate of the Protagonist

Nure, Jannat

Gumanitarnyj vektor, 2021-10, Vol.16 (4), p.46-57 [Periódico revisado por pares]

Transbaikal State University

Texto completo disponível

Citações Citado por
12
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

Bissler, John J, Prof ; Kingswood, J Christopher, FRCP ; Radzikowska, Elżbieta, MD ; Zonnenberg, Bernard A, MD ; Frost, Michael, MD ; Belousova, Elena, Prof ; Sauter, Matthias, MD ; Nonomura, Norio, Prof ; Brakemeier, Susanne, MD ; de Vries, Petrus J, Prof ; Whittemore, Vicky H, PhD ; Chen, David, PhD ; Sahmoud, Tarek, MD ; Shah, Gaurav, MD ; Lincy, Jeremie, MS ; Lebwohl, David, MD ; Budde, Klemens, Prof

The Lancet (British edition), 2013-03, Vol.381 (9869), p.817-824 [Periódico revisado por pares]

Kidlington: Elsevier

Texto completo disponível

Citações Citado por
13
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

LYNCH, Thomas J ; BONDARENKO, Igor ; RECK, Martin ; LUFT, Alexander ; SERWATOWSKI, Piotr ; BARLESI, Fabrice ; CHACKO, Raju ; SEBASTIAN, Martin ; NEAL, Joel ; HAOLAN LU ; CUILLEROT, Jean-Marie

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2046-2054 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
14
Metastatic solid pseudopapillary tumor in the perinephric fat without a primary identified focus
Metastatic solid pseudopapillary tumor in the perinephric fat without a primary identified focus
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metastatic solid pseudopapillary tumor in the perinephric fat without a primary identified focus

Surkova, V S ; Volchenko, N N ; Vorobyev, N V ; Gevorgyan, G S ; Yudakova, M E ; Tkachuk, A V

Arkhiv patologii, 2021, Vol.83 (6), p.39 [Periódico revisado por pares]

Russia (Federation)

Texto completo disponível

Citações Citado por
15
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Fuchs, Charles S, Dr Prof ; Tomasek, Jiri, MD ; Yong, Cho Jae, Prof ; Dumitru, Filip, MD ; Passalacqua, Rodolfo, MD ; Goswami, Chanchal, Prof ; Safran, Howard, Prof ; dos Santos, Lucas Vieira, MD ; Aprile, Giuseppe, MD ; Ferry, David R, Prof ; Melichar, Bohuslav, Prof ; Tehfe, Mustapha, MD ; Topuzov, Eldar, Prof ; Zalcberg, John Raymond, Prof ; Chau, Ian, MD ; Campbell, William, Prof ; Sivanandan, Choondal, MD ; Pikiel, Joanna, MD ; Koshiji, Minori, MD ; Hsu, Yanzhi, PhD ; Liepa, Astra M, PharmD ; Gao, Ling, PhD ; Schwartz, Jonathan D, MD ; Tabernero, Josep, MD

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
16
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

SEQUIST, Lecia V ; YANG, James Chih-Hsin ; SU, Wu-Chou ; BENNOUNA, Jaafar ; KATO, Terufumi ; GORBUNOVA, Vera ; KI HYEONG LEE ; SHAH, Riyaz ; MASSEY, Dan ; ZAZULINA, Victoria ; SHAHIDI, Mehdi ; SCHULER, Martin ; YAMAMOTO, Nobuyuki ; O'BYRNE, Kenneth ; HIRSH, Vera ; MOK, Tony ; GEATER, Sarayut Lucien ; ORLOV, Sergey ; TSAI, Chun-Ming ; BOYER, Michael

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3327-3334 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
17
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial

SOCINSKI, Mark A ; BONDARENKO, Igor ; IGLESIAS, Jose L ; RENSCHLER, Markus F ; KARASEVA, Nina A ; MAKHSON, Anatoly M ; VYNNYCHENKO, Igor ; OKAMOTO, Isamu ; HON, Jeremy K ; HIRSH, Vera ; BHAR, Paul ; HUI ZHANG

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2055-2062 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
18
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Material Type:
Artigo 		Adicionar ao Meu Espaço

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

VAN CUTSEM, Eric ; TABERNERO, Josep ; MCKENDRICK, Joe ; POLIKOFF, Jonathan ; TELLIER, Alexia ; CASTAN, Rémi ; ALLEGRA, Carmen ; LAKOMY, Radek ; PRENEN, Hans ; PRAUSOVA, Jana ; MACARULLA, Teresa ; RUFF, Paul ; HAZEL, Guy A. Van ; MOISEYENKO, Vladimir ; FERRY, David

Journal of clinical oncology, 2012-10, Vol.30 (28), p.3499-3506 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
19
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

JOHNSON, Philip J ; SHUKUI QIN ; LIGONG LU ; CHAO, Yee ; BOUCHER, Eveline ; HAN, Kwang-Hyub ; PAIK, Seung-Woon ; ROBLES-AVINA, Jorge ; KUDO, Masatoshi ; LUNAN YAN ; SOBHONSLIDSUK, Abhasnee ; KOMOV, Dmitry ; PARK, Joong-Won ; DECAENS, Thomas ; TAK, Won-Young ; JENG, Long-Bin ; LIU, David ; EZZEDDINE, Rana ; WALTERS, Ian ; CHENG, Ann-Lii ; POON, Ronnie T. P ; RAOUL, Jean-Luc ; PHILIP, Philip A ; HSU, Chih-Hung ; HU, Tsung-Hui ; HEO, Jeong ; JIANMING XU

Journal of clinical oncology, 2013-10, Vol.31 (28), p.3517-3524 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
20
Гендерный дисбаланс в сфере науки: объективная статистика и субъективные смыслы
Гендерный дисбаланс в сфере науки: объективная статистика и субъективные смыслы
Material Type:
Artigo 		Adicionar ao Meu Espaço

Гендерный дисбаланс в сфере науки: объективная статистика и субъективные смыслы

Таракановская, Ксения Сергеевна

Zhurnal issledovaniĭ sotsialʹnoĭ politiki, 2022-04, Vol.20 (1), p.53-66 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
previous page 1 Resultados 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (7.316)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (7.801)
  2. magazinearticle  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1977  (132)
  2. 1977Até1987  (166)
  3. 1988Até1998  (246)
  4. 1999Até2010  (2.014)
  5. Após 2010  (5.245)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (3.208)
  2. Japonês  (204)
  3. Alemão  (26)
  4. Francês  (24)
  5. Serbian  (14)
  6. Ucraniano  (11)
  7. Búlgaro  (9)
  8. Tcheco  (7)
  9. Georgiano  (3)
  10. Polonês  (1)
  11. Português  (1)
  12. Chinês  (1)
  13. Espanhol  (1)
  14. Lituano  (1)
  15. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.